Panagiotou, Orestis A

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

Kuderer, N. M., Choueiri, T. K., Shah, D. P., Shyr, Y., Rubinstein, S. M., Rivera, D. R., Shete, S., Hsu, C.-Y., Desai, A., de Lima Lopes, G., et al. (2020) · The Lancet

COVID-19 and healthcare impactsCOVID-19 Clinical Research Studies

Cited by 1,726

Evaluation of excess significance bias in animal studies of neurological diseases

Tsilidis, K. K., Panagiotou, O. A., Sena, E. S., Aretouli, E., Evangelou, E., Howells, D. W., Salman, R. A.-S., Macleod, M. R., & Ioannidis, J. P. A. (2013) · PLoS Biology

Meta-analysis and systematic reviewsAnimal testing and alternatives

Cited by 295

What should the genome-wide significance threshold be? Empirical replication of borderline genetic associations

Panagiotou, O. A., Ioannidis, J. P. A., & for the Genome-Wide Significance Project (2012) · International Journal of Epidemiology

Genetic Associations and EpidemiologyGenetic Mapping and Diversity in Plants and Animals

Cited by 286

Estimating population attributable fractions to quantify the health burden of obesity

Flegal, K. M., Panagiotou, O. A., & Graubard, B. I. (2015) · Annals of Epidemiology

Statistical Methods in EpidemiologyObesity, Physical Activity, Diet

Cited by 148

Comparative effect sizes in randomised trials from less developed and more developed countries: meta-epidemiological assessment

Panagiotou, O. A., Contopoulos-Ioannidis, D. G., & Ioannidis, J. P. A. (2013) · BMJ

Meta-analysis and systematic reviewsStatistical Methods in Clinical Trials

Cited by 89